Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

BACKGROUND & AIMS: Liver transplant (LT) recipients or other immunocompromised patients were not included in the registration trials studying the efficacy of vaccines against SARS-CoV-2. Although the clinical efficacy of COVID-19 vaccines in immunocompromised patients is unknown, many societies...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuluvath, Paul J., Robarts, Polly, Chauhan, Mahak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387568/
https://www.ncbi.nlm.nih.gov/pubmed/34454993
http://dx.doi.org/10.1016/j.jhep.2021.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387568/
https://www.ncbi.nlm.nih.gov/pubmed/34454993
http://dx.doi.org/10.1016/j.jhep.2021.08.008

Ejemplares similares